Detalhe da pesquisa
1.
TWO TREATMENT APPROACHES FOR HUMAN REGULAR U-500 INSULIN IN PATIENTS WITH TYPE 2 DIABETES NOT ACHIEVING ADEQUATE GLYCEMIC CONTROL ON HIGH-DOSE U-100 INSULIN THERAPY WITH OR WITHOUT ORAL AGENTS: A RANDOMIZED, TITRATION-TO-TARGET CLINICAL TRIAL.
Endocr Pract
; 21(7): 782-93, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25813411
2.
Impact of race/ethnicity on efficacy and safety of two starter insulin regimens in patients with type 2 diabetes: a posthoc analysis of the DURABLE trial.
Ethn Dis
; 23(4): 393-400, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24392599
3.
The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program.
J Clin Endocrinol Metab
; 94(2): 449-55, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19017751
4.
Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes.
Postgrad Med
; 128(4): 409-17, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26982554
5.
Associations between Psychosocial and Physiological Factors and Diabetes Health Indicators in Asian and Pacific Islander Adults with Type 2 Diabetes.
Nurs Res Pract
; 2013: 703520, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24282635
6.
Changes in fasting plasma glucose levels with ribavirin and pegylated interferon treatment in normal and impaired glucose tolerant patients with chronic hepatitis C.
Hawaii J Med Public Health
; 71(5): 129-31, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22737650
7.
Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs.
Diabetes Res Clin Pract
; 96(3): e66-9, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22421598
8.
A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes.
Diabetes Care
; 35(11): 2140-7, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22787177
9.
Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
PLoS One
; 7(9): e44424, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22984506
10.
Concomitant oral antihyperglycemic agent use and associated treatment outcomes after initiation of insulin therapy.
Endocr Pract
; 17(4): 563-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21550959
11.
A 47, XXY patient and Xq21.31 duplication with features of Prader-Willi syndrome: results of array-based comparative genomic hybridization.
Endocrine
; 37(3): 379-82, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20960156
12.
Ethnic differences and ß-cell changes.
J Clin Endocrinol Metab
; 98(9): 3595-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24014815
13.
Response to Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147.
Diabetes Care
; 36(7): e107-8, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23801809
14.
Clinical experience with exenatide in predominantly Asian and Pacific Islander patients with type 2 diabetes.
Endocrine
; 32(3): 311-6, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18266113